Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimiliano Anzaldi

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|March 7, 2012
Inflammation in peripheral arterial disease (PAD)Salvatore Santo Signorelli, Massimiliano Anzaldi, Valerio Fiore
Neuropathology : Official Journal of the Japanese Society of Neuropathology|September 12, 2006
Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer's disease and vascular dementiaLucia Malaguarnera, Massimo Motta, Michelino Di Rosa, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 1, 2013
Thrombophilia in Patients With Lower Limb Deep Veins Thrombosis (LDVT) Results of a Monocentric Survey on 103 Consecutive OutpatientsSalvatore Santo Signorelli, Valerio Fiore, Giuseppe Puccia, et al.
Archives of Gerontology and Geriatrics|July 2, 2010
Prevalence of high ankle-brachial index (ABI) in general population of Southern Italy, risk factor profiles and systemic cardiovascular co-morbidity: an epidemiological studySalvatore Santo Signorelli, Valerio Fiore, Stefano Catanzaro, et al.
Angiology|June 16, 2010
Study on unrecognized peripheral arterial disease (PAD) by ankle/brachial index and arterial comorbidity in Catania, Sicily, ItalySalvatore Santo Signorelli, Massimiliano Anzaldi, Valerio Fiore, et al.
Clinical Kidney Journal|August 25, 2022
GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the artAntonio Granata, Rosario Maccarrone, Massimiliano Anzaldi, et al.
Vascular Medicine (London, England)|June 1, 2014
ICAM-1 and SRD5A1 gene polymorphisms in symptomatic peripheral artery diseaseVincenza Barresi, Salvatore S Signorelli, Nicolò Musso, et al.
Cytokine|May 19, 2012
Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjectsSalvatore Santo Signorelli, Massimiliano Anzaldi, Valerio Fiore, et al.
Molecular Medicine Reports|April 9, 2013
Neopterin: a potential marker in chronic peripheral arterial diseaseSalvatore Santo Signorelli, Massimiliano Anzaldi, Valerio Fiore, et al.
International Journal of Molecular Medicine|May 28, 2011
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patientsMarco Donia, Massimiliano Anzaldi, Roberto Di Marco, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|March 7, 2012
Inflammation in peripheral arterial disease (PAD)Salvatore Santo Signorelli, Massimiliano Anzaldi, Valerio Fiore
Neuropathology : Official Journal of the Japanese Society of Neuropathology|September 12, 2006
Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer's disease and vascular dementiaLucia Malaguarnera, Massimo Motta, Michelino Di Rosa, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 1, 2013
Thrombophilia in Patients With Lower Limb Deep Veins Thrombosis (LDVT) Results of a Monocentric Survey on 103 Consecutive OutpatientsSalvatore Santo Signorelli, Valerio Fiore, Giuseppe Puccia, et al.
Archives of Gerontology and Geriatrics|July 2, 2010
Prevalence of high ankle-brachial index (ABI) in general population of Southern Italy, risk factor profiles and systemic cardiovascular co-morbidity: an epidemiological studySalvatore Santo Signorelli, Valerio Fiore, Stefano Catanzaro, et al.
Angiology|June 16, 2010
Study on unrecognized peripheral arterial disease (PAD) by ankle/brachial index and arterial comorbidity in Catania, Sicily, ItalySalvatore Santo Signorelli, Massimiliano Anzaldi, Valerio Fiore, et al.
Clinical Kidney Journal|August 25, 2022
GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the artAntonio Granata, Rosario Maccarrone, Massimiliano Anzaldi, et al.
Vascular Medicine (London, England)|June 1, 2014
ICAM-1 and SRD5A1 gene polymorphisms in symptomatic peripheral artery diseaseVincenza Barresi, Salvatore S Signorelli, Nicolò Musso, et al.
Cytokine|May 19, 2012
Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjectsSalvatore Santo Signorelli, Massimiliano Anzaldi, Valerio Fiore, et al.
Molecular Medicine Reports|April 9, 2013
Neopterin: a potential marker in chronic peripheral arterial diseaseSalvatore Santo Signorelli, Massimiliano Anzaldi, Valerio Fiore, et al.
International Journal of Molecular Medicine|May 28, 2011
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patientsMarco Donia, Massimiliano Anzaldi, Roberto Di Marco, et al.
Pageof 2